Campbell David Alan
- SEC CIK
- 0001864158
In the past year, 1 open-market sale filing worth $110.8K and no purchases.
Current role at each company
- JANX Janux Therapeutics, Inc.President and CEOas of Jul 31, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $110.8K
- 1 filing
- Net
- −$110.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Campbell David Alan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 (view filing) | Jan 2 | Same day | Campbell David AlanPresident and CEO | SSale | −8.07K | $13.73 | −$110.8K | −2.8%285.0K after | |
| Jan 8, 2025 (view filing) | Jan 7 | 1 day | Campbell David AlanPresident and CEO | SSale | −5.00K | $60.00 | −$300.0K | −1.7%293.1K after | 10b5-1 |
| Dec 27, 2024 (view filing) | Dec 24 | 3 days | Campbell David AlanPresident and CEO | SSale | −25.0K | $56.19 | −$1.40M | −10.3%217.1K after | 10b5-1 |
| Dec 3, 2024 (view filing) | Dec 3 | Same day | Campbell David AlanPresident and CEO | SSale | −15.0K | $67.00 | −$1.00M | −5.8%242.1K after | 10b5-1 |
| Nov 27, 2024 (view filing) | Nov 25 | 2 days | Campbell David AlanPresident and CEO | SSale | −25.0K | $51.59 | −$1.29M | −8.9%257.1K after | 2 lots10b5-1 |
| Oct 30, 2024 (view filing) | Oct 28 | 2 days | Campbell David AlanPresident and CEO | SSale | −25.0K | $53.54 | −$1.34M | −8.1%282.1K after | 2 lots10b5-1 |
| Sep 27, 2024 (view filing) | Sep 27 | Same day | Campbell David AlanPresident and CEO | SSale | −25.0K | $46.31 | −$1.16M | −7.5%307.1K after | 3 lots10b5-1 |